ask="16.75"
ask_size="100"
average_daily_volume="159650"
bid="10.22"
bid_size="100"
book_value="0.00"
change="+0.42"
change_from_200_day_moving_average="6.30"
change_from_50_day_moving_average="0.84"
change_from_52_week_high="-3.00"
change_From_52_week_low="4.70"
change_in_percent="+4.05%"
close="10.80"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-1.55"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="10.95"
high_52_weeks="13.80"
last_trade_date="3/1/2017"
last_trade_price="10.80"
last_trade_size="300"
last_trade_time="4:00pm"
low="10.41"
low_52_weeks="6.10"
market_capitalization="N/A"
moving_average_200_day="4.50"
moving_average_50_day="9.96"
name="Novelion Therapeutics Inc. "
notes="N/A"
one_year_target_price="10.00"
open="10.41"
pe_ratio="N/A"
peg_ratio="0.15"
percent_change_from_200_day_moving_average="+140.21%"
percent_change_from_50_day_moving_average="+8.39%"
percent_change_from_52_week_high="-21.74%"
percent_change_from_52_week_low="+77.05%"
previous_close="10.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="201906"
weeks_range_52="6.10 - 13.80"
